Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway

McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member, Nature, 387, 83, 10.1038/387083a0

Lee, 2001, Regulation of myostatin activity and muscle growth, Proc. Natl. Acad. Sci. USA, 98, 9306, 10.1073/pnas.151270098

Grobet, 1998, Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle, Mamm. Genome: Off. J. Int. Mamm. Genome Soc., 9, 210, 10.1007/s003359900727

Kambadur, 1997, Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle, Genome Res., 7, 910, 10.1101/gr.7.9.910

McPherron, 1997, Double muscling in cattle due to mutations in the myostatin gene, Proc. Natl. Acad. Sci. USA, 94, 12457, 10.1073/pnas.94.23.12457

Mosher, 2007, A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs, PLoS Genet., 3, e79, 10.1371/journal.pgen.0030079

Clop, 2006, A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep, Nature Genet., 38, 813, 10.1038/ng1810

Schuelke, 2004, Myostatin mutation associated with gross muscle hypertrophy in a child, N. Engl. J. Med., 350, 2682, 10.1056/NEJMoa040933

Lee, 2004, Regulation of muscle mass by myostatin, Ann. Rev. Cell Dev. Biol., 20, 61, 10.1146/annurev.cellbio.20.012103.135836

Rebbapragada, 2003, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis, Mol. Cell. Biol., 23, 7230, 10.1128/MCB.23.20.7230-7242.2003

Langley, 2002, Myostatin inhibits myoblast differentiation by down-regulating MyoD expression, J. Biol. Chem., 277, 49831, 10.1074/jbc.M204291200

Bogdanovich, 2002, Functional improvement of dystrophic muscle by myostatin blockade, Nature, 420, 418, 10.1038/nature01154

Zhu, 2004, Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism, Cytokine, 26, 262, 10.1016/j.cyto.2004.03.007

Sarbassov, 2005, Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 17, 596, 10.1016/j.ceb.2005.09.009

Bodine, 2001, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo, Nat. Cell Biol., 3, 1014, 10.1038/ncb1101-1014

Pallafacchina, 2002, A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification, Proc. Natl. Acad. Sci. USA, 99, 9213, 10.1073/pnas.142166599

Lai, 2004, Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy, Mol. Cell. Biol., 24, 9295, 10.1128/MCB.24.21.9295-9304.2004

Morissette, 2009, Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt, Am. J. Physiol. Cell Physiol., 297, C1124, 10.1152/ajpcell.00043.2009

Trendelenburg, 2009, Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size, Am. J. Physiol. Cell Physiol., 296, C1258, 10.1152/ajpcell.00105.2009

Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle, Endocrinology, 150, 286, 10.1210/en.2008-0959

Sartori, 2009, Smad2 and 3 transcription factors control muscle mass in adulthood, Am. J. Physiol. Cell Physiol., 296, C1248, 10.1152/ajpcell.00104.2009

Perry, 2000, Molecular mechanisms regulating myogenic determination and differentiation, Front. Biosci. J. Virtual Lib., 5, D750, 10.2741/A548

Joulia-Ekaza, 2006, Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects, Exp. Cell Res., 312, 2401, 10.1016/j.yexcr.2006.04.012

Oldham, 2001, Molecular expression of myostatin and MyoD is greater in double-muscled than normal-muscled cattle fetuses, Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R1488, 10.1152/ajpregu.2001.280.5.R1488

Yang, 2001, Expression of myostatin pro domain results in muscular transgenic mice, Mol. Reprod. Dev., 60, 351, 10.1002/mrd.1097

Kim, 2011, The muscle-hypertrophic effect of clenbuterol is additive to the hypertrophic effect of myostatin suppression, Muscle Nerve, 43, 700, 10.1002/mus.21950

Deblon, 2012, Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats, Br. J. Pharmacol., 165, 2325, 10.1111/j.1476-5381.2011.01716.x

Houde, 2010, Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue, Diabetes, 59, 1338, 10.2337/db09-1324

Miller, 2011, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice, J. Gerontol. A-Biol., 66, 191, 10.1093/gerona/glq178

Shioi, 2003, Rapamycin attenuates load-induced cardiac hypertrophy in mice, Circulation, 107, 1664, 10.1161/01.CIR.0000057979.36322.88

Araujo, 2014, Effect of rapamycin on spleen size in longstanding renal transplant recipients, Transplant. Proc., 46, 1319, 10.1016/j.transproceed.2014.03.011

Cen, 2011, Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma, Mol. Cancer Ther., 10, 679, 10.1158/1535-7163.MCT-10-0833

Chang, 2009, Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice, J. Pharmacol. Sci., 109, 496, 10.1254/jphs.08215FP

Amthor, 2009, Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity, Proc. Natl. Acad. Sci. USA, 106, 7479, 10.1073/pnas.0811129106

Lee, 2012, Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway, Proc. Natl. Acad. Sci. USA, 109, E2353, 10.1073/pnas.1206410109

Rachagani, 2010, Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle, BMC Res. Notes, 3, 297, 10.1186/1756-0500-3-297

Loughna, 1996, Two myogenic regulatory factor transcripts exhibit muscle-specific responses to disuse and passive stretch in adult rats, FEBS Lett., 390, 304, 10.1016/0014-5793(96)00681-3

Lowe, 1998, Hypertrophy-stimulated myogenic regulatory factor mRNA increases are attenuated in fast muscle of aged quails, Am. J. Physiol., 275, C155, 10.1152/ajpcell.1998.275.1.C155

Wen, 2017, Effects of dietary methionine on breast muscle growth, myogenic gene expression and IGF-I signaling in fast- and slow-growing broilers, Sci. Rep., 7, 1924, 10.1038/s41598-017-02142-z

Moretti, 2016, MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity, Nat. Commun., 7, 12397, 10.1038/ncomms12397

Sandri, 2008, Signaling in muscle atrophy and hypertrophy, Physiology, 23, 160, 10.1152/physiol.00041.2007

Wang, 2006, The mTOR pathway in the control of protein synthesis, Physiology, 21, 362, 10.1152/physiol.00024.2006

Baar, 1999, Phosphorylation ofp70(S6k) correlates with increased skeletal muscle mass following resistance exercise, Am. J. Physiol., 276, C120, 10.1152/ajpcell.1999.276.1.C120

Glover, 2008, Resistance exercise decreases eIF2Bepsilon phosphorylation and potentiates the feeding-induced stimulation of p70S6K1 and rpS6 in young men, Am. J. Physiol. Regul. Integr. Comp. Physiol., 295, R604, 10.1152/ajpregu.00097.2008

O'Neil, 2009, The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions, J. Physiol., 587, 3691, 10.1113/jphysiol.2009.173609

Dreyer, 2008, Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle, Am. J. Physiol. Endocrinol. Metab., 294, E392, 10.1152/ajpendo.00582.2007

Gao, 2014, Rapamycin represses myotube hypertrophy and preserves viability of C2C12 cells during myogenesis in vitro, Transplantation, 98, 139, 10.1097/TP.0000000000000175